Opportunity: CRISPR gene-editing of the ACVR1 and TGFBR1 genes

Description 

CRISPR gene-editing of the ACVR1 and TGFBR1 genes in endometrial cancer cell lines.

Overview 
Reference number: 75N92021Q0172
Issue date: 07/22/2021
Response due: 07/28/2021 11:30 AM US/Eastern

Set Aside:
NAICS: 541714-Research and Development in Biotechnology (except Nanobiotechnology)
PSC / FSC: R499-SUPPORT- PROFESSIONAL: OTHER

Agency: NHLBI

Contracting office:

Shevenie Castillo, Contract Spec.
National Institutes of Health
National Heart, Lung, and Blood Ins
301-827-6777
Bethesda, MD 20892-7902


Place of Performance:




Contact: Dorothy Maxwell
Phone:
Fax:
Email: dorothy.maxwell@nih.gov

Vendors conference:

Location:



Details:



What do I do now?
This is the opportunity summary page. To the left you will see a description and an overview of this opportunity. To the right you will see a list of the attached documentation. To view any of the attachments, simply click the attachment name.



Registered Users
To register interest in this opportunity or to electronically respond, you must first sign in. Click the Sign In button below.





Non Registered Users
You can view this or any other public opportunity. However, registered users have numerous added benefits including the ability to submit questions to the agency, receive emails concerning updates and amendments, create and manage a response team and submit responses directly through this site.

Becoming a registered user is fast, free and takes only a few minutes. To get started, click the Register Now button below.

  




Documentation 

Terms of Service and Use About FedConnect